Last action was on 3-5-2025
Current status is Referred to the Committee on Science, Space, and Technology, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
View Official Bill Information at congress.govNo users have voted for/against support on this bill yet. Be the first!
This Act may be cited as the "Risky Research Review Act".
(a) In general - Subtitle V of title 31, United States Code, is amended by adding at the end the following:
(b) Clerical amendment - The table of chapters for subtitle V of title 31, United States Code, is amended by adding at the end the following:
(c) Financial disclosure reports of Board members - Section 13103(f) of title 5, United States Code, is amended—
(1) - in paragraph (11), by striking "and" at the end;
(2) - in paragraph (12), by striking the period at the end and inserting "; and"; and
(3) - by adding at the end the following:
(13) - a member of the Life Sciences Research Security Board established under section 7902 of title 31.